Glyconutrients in the News
Sent: Tuesday, August 15, 2006 10:02 PM
Subject: Emory to study Emerging Field of Gyconomics
Atached is a press release from Emory University School of Medicine announcing the appointment of Glycomics Expert, Dr. Richard Cummings, as the new chair of the Department of Biochemistry. The article states that "the National Institutes of Health has identified the field of glycomics as a major new research focus. Glycomics is defined as the scientific pursuit of identifying and studying all of the carbohydrate molecules produced by an organism. Dr. Cummings' research focuses on glycoconjugates, the carbohydrate molecules and their associated proteins that permit cells to communicate with and ahere to each other -- transmitting and receiving chemical, electrical and mechanical messages that underlie all cellular and bodily functions."
This should sound familiar to all of you. The primary function of the glyconutrients you are taking is the communication between cells which "underlies all bodily functions." There is a tremendous amount of research ongoing by many prestigous institutions. It is very exciting to see that Emory University School of Medicine has joined this endeavor. As Georgians, it is exciting that two of our major universities ("The Complex Carbohydrate Center" at UGA and Emory School of Medicine) are now at the forefront of this new frontier in medicine--the science of Glycobiology. See the press release below.
Emory School of Medicine Names 'Glycomics' Expert As New Chair of Biochemistry
Emory University School of Medicine has named Richard D. Cummings, PhD, a nationally recognized expert in the emerging research field of 'glycomics,' as the new chair of the Department of Biochemistry. Before joining the Emory faculty in June, Dr. Cummings was George Lynn Cross Distinguished Research Professor of Biochemistry and Molecular Biology at the University of Oklahoma Health Sciences Center. He held the Ed Miller Endowed Chair in Molecular Biology, was a professor of biochemistry and molecular biology, and was director and founder of the Oklahoma Center for Medical Glycobiology.
In 1999, Dr. Cummings was appointed co-director/coordinator of the newly established University of Oklahoma Bioengineering Center. Before joining the University of Oklahoma, he was professor of biochemistry at the University of Georgia and associate director of the UGA Complex Carbohydrate Research Center.
The National Institutes of Health (NIH) has identified the field of glycomics as a major new research focus, and Dr. Cummings has played a key role in the multi-institutional Consortium for Functional Glycomics funded by the National Institute of General Medical Sciences (NIGMS). Glycomics is defined as the scientific pursuit of identifying and studying all of the carbohydrate molecules produced by an organism.
Dr. Cummings' research focuses on glycoconjugates, the carbohydrate molecules and their associated proteins that permit cells to communicate with and adhere to each other--transmitting and receiving chemical, electrical and mechanical messages that underlie all cellular and bodily functions. His research has a particular emphasis on the role of glycoconjugates in cardiovascular biology, autoimmune diseases, and parasitology. A hallmark of his research team has been the promotion of collaborative studies and training in glycobiology, and he has partnerships with more than a dozen other laboratories.
"It is my great honor to become the chair of the Department of Biochemistry at Emory University School of Medicine," said Dr. Cummings. "It is a privilege to join such an outstanding group of faculty, fellows, students and staff. I look forward to working with everyone in the coming years to help the department grow and continue to be recognized for its outstanding research and teaching. I also want to acknowledge the excellent work of Dr. Dean Danner, who has served as interim chair, and thank him for his service."
"I am very pleased to have Dr. Cummings join our School of Medicine, particularly as one of the initiatives in the University's new Strategic Plan is fundamental scientific research," said Thomas J. Lawley, MD, dean, Emory University School of Medicine. "Dr. Cummings is widely recognized as a ground breaker in biochemistry, and his leadership will be invaluable as we move past the human genome project into undiscovered territory and the next level of medical advancement."
Dr. Cummings received his bachelor's degree in 1974 from the University of Montevallo in Montevallo, Alabama and his doctoral degree in 1980 from The Johns Hopkins University. He was a postdoctoral fellow in Hematology/Oncology at the Washington University School of Medicine in St. Louis.
Frazzled Dad Mike, who has been using glyconutrients since 1998, and makes sure his children get them every day is excited to see more research in this field.
Subject: Emory to study Emerging Field of Gyconomics
Atached is a press release from Emory University School of Medicine announcing the appointment of Glycomics Expert, Dr. Richard Cummings, as the new chair of the Department of Biochemistry. The article states that "the National Institutes of Health has identified the field of glycomics as a major new research focus. Glycomics is defined as the scientific pursuit of identifying and studying all of the carbohydrate molecules produced by an organism. Dr. Cummings' research focuses on glycoconjugates, the carbohydrate molecules and their associated proteins that permit cells to communicate with and ahere to each other -- transmitting and receiving chemical, electrical and mechanical messages that underlie all cellular and bodily functions."
This should sound familiar to all of you. The primary function of the glyconutrients you are taking is the communication between cells which "underlies all bodily functions." There is a tremendous amount of research ongoing by many prestigous institutions. It is very exciting to see that Emory University School of Medicine has joined this endeavor. As Georgians, it is exciting that two of our major universities ("The Complex Carbohydrate Center" at UGA and Emory School of Medicine) are now at the forefront of this new frontier in medicine--the science of Glycobiology. See the press release below.
Emory School of Medicine Names 'Glycomics' Expert As New Chair of Biochemistry
Emory University School of Medicine has named Richard D. Cummings, PhD, a nationally recognized expert in the emerging research field of 'glycomics,' as the new chair of the Department of Biochemistry. Before joining the Emory faculty in June, Dr. Cummings was George Lynn Cross Distinguished Research Professor of Biochemistry and Molecular Biology at the University of Oklahoma Health Sciences Center. He held the Ed Miller Endowed Chair in Molecular Biology, was a professor of biochemistry and molecular biology, and was director and founder of the Oklahoma Center for Medical Glycobiology.
In 1999, Dr. Cummings was appointed co-director/coordinator of the newly established University of Oklahoma Bioengineering Center. Before joining the University of Oklahoma, he was professor of biochemistry at the University of Georgia and associate director of the UGA Complex Carbohydrate Research Center.
The National Institutes of Health (NIH) has identified the field of glycomics as a major new research focus, and Dr. Cummings has played a key role in the multi-institutional Consortium for Functional Glycomics funded by the National Institute of General Medical Sciences (NIGMS). Glycomics is defined as the scientific pursuit of identifying and studying all of the carbohydrate molecules produced by an organism.
Dr. Cummings' research focuses on glycoconjugates, the carbohydrate molecules and their associated proteins that permit cells to communicate with and adhere to each other--transmitting and receiving chemical, electrical and mechanical messages that underlie all cellular and bodily functions. His research has a particular emphasis on the role of glycoconjugates in cardiovascular biology, autoimmune diseases, and parasitology. A hallmark of his research team has been the promotion of collaborative studies and training in glycobiology, and he has partnerships with more than a dozen other laboratories.
"It is my great honor to become the chair of the Department of Biochemistry at Emory University School of Medicine," said Dr. Cummings. "It is a privilege to join such an outstanding group of faculty, fellows, students and staff. I look forward to working with everyone in the coming years to help the department grow and continue to be recognized for its outstanding research and teaching. I also want to acknowledge the excellent work of Dr. Dean Danner, who has served as interim chair, and thank him for his service."
"I am very pleased to have Dr. Cummings join our School of Medicine, particularly as one of the initiatives in the University's new Strategic Plan is fundamental scientific research," said Thomas J. Lawley, MD, dean, Emory University School of Medicine. "Dr. Cummings is widely recognized as a ground breaker in biochemistry, and his leadership will be invaluable as we move past the human genome project into undiscovered territory and the next level of medical advancement."
Dr. Cummings received his bachelor's degree in 1974 from the University of Montevallo in Montevallo, Alabama and his doctoral degree in 1980 from The Johns Hopkins University. He was a postdoctoral fellow in Hematology/Oncology at the Washington University School of Medicine in St. Louis.
Frazzled Dad Mike, who has been using glyconutrients since 1998, and makes sure his children get them every day is excited to see more research in this field.
posted by Mike Logan at 1:29 PM
0 comments
